Rating
Hold
Price target
$220
Previous
$190
Implied upside
+11%

Cantor Fitzgerald analyst C.J.

Muse raised the price target on Marvell Technology (NASDAQ: MRVL) to $220.00 (from $190.00) while maintaining a Neutral rating.

“With MRVL benefiting from many architectural pieces for AIoptimized infrastructure (high-speed optical interconnect, switching, Serdes, I/O, etc.), the company’s outlook suggests CY28 EPS approaching $10 (cons $7.65).

Now, obviously, the stock run from ~$80 in early March to ~$200 today reflects much of this upside.

We have heard more bullish expectations from some investors ($12+), and it is clearly very early for Marvell to provide a guide for CY28 – so those bullish expectations likely remain.

But assuming a path to $10, we raise our price target to $220 (from $190), representing 22x CY28 EPS. Considering only ~10% upside, we reiterate our Neutral rating.

We do view AI compute sold out as a clear rising tide for Marvell and accelerator peers – so bias will be higher over time – but with NVDA/AVGO trading only ~14x/~17x stretch goal CY27 EPS (and MRVL ~29x) we simply see better upside elsewhere.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.